Business ❯ Pharmaceutical Industry

Vaccine Development

Pfizer Moderna COVID-19 Vaccines Market Impact Corporate Governance Market Reactions mRNA Technology Valneva Moderna Inc. AstraZeneca Patent Disputes Covid-19 Vaccines COVID-19 Response Intellectual Property Rights Technology Transfer Product Liability Biontech/Pfizer Contracts Corporate Communication Market Competition Partnerships COVID-19 Vaccine Manufacturers Emergency Use Authorization Funding Research Funding Market Trends Funding Impact Funding Projects Funding Allocations Investment in Health Drug Manufacturers Market Performance Regulatory Challenges Corporate Influence Funding Policies Johnson & Johnson Operation Warp Speed Bavarian Nordic Regulatory Approval Regulatory Agencies BioNTech Combination Vaccines Market Demand Novavax Market Dynamics Public Trust Market Regulation Regulatory Policy Innovation in Healthcare

Moderna Scraps CMV Vaccine Program After Phase 3 Failure

The company says the setback does not change its financial outlook.

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine